Company Overview of Astorg Partners
Astorg Partners is a private equity firm specializing in leveraged build-ups in mature middle market companies. The firm also makes control investments in mid-sized companies with growth capital, family transmissions, mid cap owner and leveraged buyouts, and corporate spin-offs. It invests in small to midcap companies primarily in all sectors with a focus on healthcare, industrial and service companies, B2B global niche leading companies, selling differentiated products or services, and occasionally invests in B2C companies, consumer staples, diversified support services, professional services, and retail. Within healthcare, the firm invests in services, diagnosis, and pharmaceuticals. Withi...
68, rue du Faubourg Saint-Honoré
Founded in 1998
Key Executives for Astorg Partners
Chairman, Co-Founder, President, and Managing Partner
Partner and Chief Operating Officer
Compensation as of Fiscal Year 2016.
Astorg Partners Key Developments
Astorg And Buyout Groups Are In The Running to acquire Autoform
Jun 24 16
Astorg Partners has agreed to acquire Swiss industrial software group Autoform for almost 700 million Swiss Francs. HgCapital and TA Associates (UK), LP were runners-up in the auction.
Astorg Entered Into Exclusive Negotiations With PAI Partners For The Sale Of Ethypharm
May 10 16
Astorg Partners announced that they have entered into exclusive negotiations with PAI Partners for the acquisition of Ethypharm S.A. alongside Ethypharm's management team. The equity for the transaction would be provided by PAI Europe VI, PAI's latest €3.3 billion fund. The offer of PAI is subject to the consultation process of the relevant "Comités d'entreprise" (French employee works councils) and all parties will enter into the final negotiations on successful completion of this process. Hugues Lecat, Chief Executive Officer of Ethypharm, said: "We are proud of Ethypharm's achievements to date and believe PAI's institutional support would facilitate our plans for international expansion and for development as a specialty pharmaceutical company. We look forward to working with PAI and are thankful to Astorg for their unconditional support over the last years." Edward Chandler, Partner at PAI commented: "We are delighted to partner with Hugues Lecat and his team to support the continued growth and success of Ethypharm. The company has an excellent management team, a clear vision of what it is seeking to achieve, and a bright future as a specialty pharmaceutical company."
Carlyle Group In Talks To Buy Saverglass
Dec 17 15
The Carlyle Group LP (NasdaqGS:CG) is in talks with Astorg Partners to acquire majority controlling stake in Saverglass sas. Loïc Quentin de Gromard, Chief Executive Officer, Saverglass, said, “The exciting and promising partnership envisaged with Carlyle would take place at the end of a challenging period in the Wine and Spirit industry." Rothschild acted as financial advisor to Astorg and the management of Saverglass.
Similar Private Companies By Industry
Recent Private Companies Transactions